Glaxosmithkline Pharmaceuticals consolidated net profit rises 8406.98% in the March 2022 quarter

Sales rise 8.76% to Rs 809.63 crore

Net profit of Glaxosmithkline Pharmaceuticals rose 8406.98% to Rs 1219.05 crore in the quarter ended March 2022 as against Rs 14.33 crore during the previous quarter ended March 2021. Sales rose 8.76% to Rs 809.63 crore in the quarter ended March 2022 as against Rs 744.43 crore during the previous quarter ended March 2021.

For the full year,net profit rose 373.19% to Rs 1694.72 crore in the year ended March 2022 as against Rs 358.15 crore during the previous year ended March 2021. Sales rose 12.05% to Rs 3278.03 crore in the year ended March 2022 as against Rs 2925.60 crore during the previous year ended March 2021.

 

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales809.63744.43 9 3278.032925.60 12 OPM %21.6421.05 -23.2420.45 - PBDT1467.41196.33 647 2149.61776.07 177 PBT1452.06178.65 713 2081.42697.47 198 NP1219.0514.33 8407 1694.72358.15 373

Powered by Capital Market - Live News